|
|
|
xiii | |
| Acknowledgments |
|
xvii | |
| Introduction |
|
xix | |
|
1 Surgical Anatomy of the Breast |
|
|
1 | (12) |
|
|
|
|
|
1.1 Topology of the Breast: An Overview |
|
|
1 | (1) |
|
|
|
2 | (1) |
|
|
|
2 | (1) |
|
1.4 Ligaments of Cooper and Horizontal Septum |
|
|
3 | (1) |
|
1.5 Arterial Supply of the Breast |
|
|
3 | (4) |
|
1.6 Venous Drainage of the Breast |
|
|
7 | (1) |
|
|
|
7 | (1) |
|
|
|
8 | (1) |
|
1.9 Nipple Areola Complex |
|
|
9 | (4) |
|
|
|
10 | (3) |
|
2 Surgical Landmarks and Measurements |
|
|
13 | (14) |
|
|
|
|
|
|
|
14 | (1) |
|
|
|
15 | (7) |
|
2.3 Vertical Mastopexy/Reduction Markings |
|
|
22 | (5) |
|
|
|
25 | (2) |
|
|
|
27 | (30) |
|
|
|
|
|
|
|
|
|
27 | (1) |
|
|
|
28 | (3) |
|
|
|
31 | (3) |
|
3.4 Predictors of Response |
|
|
34 | (4) |
|
|
|
38 | (1) |
|
3.6 Hormone Receptor-Positive Tumors |
|
|
38 | (3) |
|
3.7 Invasive Lobular Carcinoma |
|
|
41 | (1) |
|
|
|
41 | (4) |
|
3.9 Locoregional Failure: Incidence and Predictors |
|
|
45 | (1) |
|
3.10 Predictors of Relapse |
|
|
46 | (1) |
|
|
|
47 | (1) |
|
|
|
48 | (9) |
|
|
|
52 | (5) |
|
|
|
57 | (8) |
|
|
|
|
|
60 | (2) |
|
4.2 Inframammary Incision |
|
|
62 | (1) |
|
|
|
62 | (3) |
|
|
|
63 | (2) |
|
5 Margins in Breast Cancer Surgery |
|
|
65 | (22) |
|
|
|
|
|
5.1 Methods of Margin Evaluation |
|
|
66 | (5) |
|
5.2 Margin Width and Local Recurrence: Invasive Cancer |
|
|
71 | (7) |
|
5.3 Margin Width and Local Recurrence: DCIS |
|
|
78 | (9) |
|
|
|
80 | (7) |
|
|
|
87 | (12) |
|
|
|
6.1 General Principles and Preoperative Planning |
|
|
87 | (2) |
|
6.2 Resection of the Primary |
|
|
89 | (10) |
|
|
|
96 | (3) |
|
7 Repair of Breast Defects |
|
|
99 | (30) |
|
|
|
|
|
100 | (29) |
|
|
|
127 | (2) |
|
8 Oncoplastic Breast Reduction |
|
|
129 | (30) |
|
|
|
|
|
|
|
|
|
|
|
129 | (1) |
|
8.2 The Oncoplastic Approach |
|
|
130 | (1) |
|
8.3 Patient Selection and Preoperative Breast Evaluation |
|
|
131 | (2) |
|
|
|
133 | (1) |
|
8.5 Types of Breast Reduction |
|
|
133 | (1) |
|
|
|
134 | (1) |
|
8.7 Technical Considerations |
|
|
135 | (1) |
|
|
|
136 | (1) |
|
|
|
137 | (13) |
|
|
|
150 | (1) |
|
|
|
151 | (1) |
|
8.12 Long-Term Oncologic Results |
|
|
151 | (1) |
|
8.13 Breast Cancer Surveillance |
|
|
152 | (1) |
|
8.14 Cosmetic and Functional Outcomes |
|
|
153 | (1) |
|
|
|
154 | (5) |
|
|
|
154 | (5) |
|
|
|
159 | (18) |
|
|
|
|
|
159 | (1) |
|
|
|
160 | (12) |
|
|
|
172 | (5) |
|
|
|
176 | (1) |
|
10 Skin-Sparing Mastectomy |
|
|
177 | (16) |
|
|
|
|
|
|
|
177 | (1) |
|
|
|
178 | (5) |
|
|
|
183 | (1) |
|
|
|
184 | (1) |
|
|
|
185 | (1) |
|
|
|
186 | (1) |
|
10.7 Postoperative Complications |
|
|
186 | (1) |
|
10.8 Completeness of Mastectomy |
|
|
187 | (1) |
|
10.9 Completeness of Tumor Removal and Local Recurrence Rates |
|
|
187 | (1) |
|
|
|
188 | (5) |
|
|
|
189 | (4) |
|
11 Nipple-Sparing Mastectomy |
|
|
193 | (22) |
|
|
|
|
|
|
|
193 | (1) |
|
|
|
194 | (1) |
|
11.3 Why Not Perform NSM? |
|
|
194 | (1) |
|
11.4 Most Frequently Cited Landmark Study |
|
|
194 | (1) |
|
|
|
195 | (1) |
|
|
|
195 | (2) |
|
|
|
197 | (1) |
|
11.8 Exclusionary Criteria |
|
|
198 | (1) |
|
11.9 Preoperative Evaluation |
|
|
198 | (1) |
|
11.10 Plastic Reconstructive Surgery Considerations |
|
|
199 | (1) |
|
|
|
200 | (1) |
|
11.12 Intraoperative Technique |
|
|
200 | (5) |
|
|
|
205 | (2) |
|
11.14 Additional Technical Notes |
|
|
207 | (1) |
|
11.15 Intraoperative Radiation with Electrons (ELIOT) |
|
|
207 | (1) |
|
|
|
208 | (2) |
|
|
|
210 | (1) |
|
11.18 Summary and Conclusions |
|
|
210 | (5) |
|
|
|
211 | (4) |
|
|
|
215 | (12) |
|
|
|
|
|
215 | (1) |
|
12.2 Oncoplastic Surgery and 5-Day Interstitial Brachytherapy |
|
|
216 | (6) |
|
12.3 Oncoplastic Surgery with 3-Dimensional Conformal PBI |
|
|
222 | (1) |
|
12.4 Intraoperative Radiotherapy During Oncoplastic Surgery |
|
|
222 | (2) |
|
|
|
224 | (3) |
|
|
|
224 | (3) |
| Index |
|
227 | |